These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 11572859

  • 1. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
    Yin L, Laevsky G, Giardina C.
    J Biol Chem; 2001 Nov 30; 276(48):44641-6. PubMed ID: 11572859
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
    Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, Schoonbroodt S, Goffin V, Nguyên TL, Gloire G, Carrard G, Friguet B, De Launoit Y, Burny A, Bours V, Piette J, Van Lint C.
    Mol Cell Biol; 2003 Sep 30; 23(17):6200-9. PubMed ID: 12917341
    [Abstract] [Full Text] [Related]

  • 3. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha.
    Place RF, Noonan EJ, Giardina C.
    Biochem Pharmacol; 2005 Aug 01; 70(3):394-406. PubMed ID: 15950952
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H.
    J Bone Miner Res; 2001 Jul 01; 16(7):1272-80. PubMed ID: 11450703
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR.
    J Biol Chem; 1999 Jan 08; 274(2):787-94. PubMed ID: 9873017
    [Abstract] [Full Text] [Related]

  • 6. Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate.
    Lührs H, Gerke T, Schauber J, Dusel G, Melcher R, Scheppach W, Menzel T.
    Int J Colorectal Dis; 2001 Aug 08; 16(4):195-201. PubMed ID: 11515677
    [Abstract] [Full Text] [Related]

  • 7. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
    Haas M, Page S, Page M, Neumann FJ, Marx N, Adam M, Ziegler-Heitbrock HW, Neumeier D, Brand K.
    J Leukoc Biol; 1998 Mar 08; 63(3):395-404. PubMed ID: 9500529
    [Abstract] [Full Text] [Related]

  • 8. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH, Wong HR, Odoms K, Deitch EA, Szabó C, Vizi ES, Haskó G.
    Mol Pharmacol; 2004 Feb 08; 65(2):342-9. PubMed ID: 14742676
    [Abstract] [Full Text] [Related]

  • 9. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C, Bates EE, Arrigo AP.
    J Biol Chem; 1998 Feb 06; 273(6):3180-91. PubMed ID: 9452429
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA, Owens MW, Grisham MB.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):388-95. PubMed ID: 8914937
    [Abstract] [Full Text] [Related]

  • 11. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line.
    Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C.
    Gastroenterology; 2000 Apr 15; 118(4):724-34. PubMed ID: 10734024
    [Abstract] [Full Text] [Related]

  • 12. Ubiquitin-proteasome inhibitor enhances tumour necrosis factor-alpha-induced apoptosis in rat gastric epithelial cells.
    Naito Y, Handa O, Takagi T, Ishikawa T, Imamoto E, Nakagawa S, Yamaguchi T, Yoshida N, Matsui H, Yoshikawa T.
    Aliment Pharmacol Ther; 2002 Apr 15; 16 Suppl 2():59-66. PubMed ID: 11966525
    [Abstract] [Full Text] [Related]

  • 13. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D, Wulczyn FG, Scheidereit C.
    EMBO J; 1996 Dec 02; 15(23):6716-26. PubMed ID: 8978697
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
    Fiedler MA, Wernke-Dollries K, Stark JM.
    Am J Respir Cell Mol Biol; 1998 Aug 02; 19(2):259-68. PubMed ID: 9698598
    [Abstract] [Full Text] [Related]

  • 15. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K, Shichiri M, Marumo F, Hirata Y.
    Arterioscler Thromb Vasc Biol; 1998 Nov 02; 18(11):1796-802. PubMed ID: 9812920
    [Abstract] [Full Text] [Related]

  • 16. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S, Perrin C, Akari H, Strebel K.
    J Biol Chem; 2001 May 11; 276(19):15920-8. PubMed ID: 11278695
    [Abstract] [Full Text] [Related]

  • 17. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, Zuckerman KS.
    J Biol Chem; 2002 May 10; 277(19):16528-37. PubMed ID: 11864973
    [Abstract] [Full Text] [Related]

  • 18. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation.
    Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantôme A, Plenchette S, Khochbin S, Solary E, Garrido C.
    Mol Cell Biol; 2003 Aug 10; 23(16):5790-802. PubMed ID: 12897149
    [Abstract] [Full Text] [Related]

  • 19. The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.
    Ma MH, Yang HH, Parker K, Manyak S, Friedman JM, Altamirano C, Wu ZQ, Borad MJ, Frantzen M, Roussos E, Neeser J, Mikail A, Adams J, Sjak-Shie N, Vescio RA, Berenson JR.
    Clin Cancer Res; 2003 Mar 10; 9(3):1136-44. PubMed ID: 12631619
    [Abstract] [Full Text] [Related]

  • 20. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.
    Page S, Fischer C, Baumgartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HW, Neumeier D, Brand K.
    J Biol Chem; 1999 Apr 23; 274(17):11611-8. PubMed ID: 10206970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.